Show simple item record

dc.contributor.authorReynaldi, Arnold
dc.contributor.authorSchlub, Timothy E.
dc.contributor.authorPiriou, Erwan
dc.contributor.authorOgolla, Sidney
dc.contributor.authorSumba, Odada P.
dc.contributor.authorMoormann, Ann M.
dc.contributor.authorRochford, Rosemary
dc.contributor.authorDavenport, Miles P.
dc.date2022-08-11T08:08:21.000
dc.date.accessioned2022-08-23T15:52:14Z
dc.date.available2022-08-23T15:52:14Z
dc.date.issued2016-11-01
dc.date.submitted2017-06-14
dc.identifier.citationJ Infect Dis. 2016 Nov 1;214(9):1390-1398. Epub 2016 Aug 28. <a href="https://doi.org/10.1093/infdis/jiw396">Link to article on publisher's site</a>
dc.identifier.issn0022-1899 (Linking)
dc.identifier.doi10.1093/infdis/jiw396
dc.identifier.pmid27571902
dc.identifier.urihttp://hdl.handle.net/20.500.14038/29091
dc.description.abstractThe combination of Epstein-Barr virus (EBV) infection and high malaria exposure are risk factors for endemic Burkitt lymphoma, and evidence suggests that infants in regions of high malaria exposure have earlier EBV infection and increased EBV reactivation. In this study we analyzed the longitudinal antibody response to EBV in Kenyan infants with different levels of malaria exposure. We found that high malaria exposure was associated with a faster decline of maternally derived immunoglobulin G antibody to both the EBV viral capsid antigen and EBV nuclear antigen, followed by a more rapid rise in antibody response to EBV antigens in children from the high-malaria-transmission region. We also observed the long-term persistence of anti-viral capsid antigen immunoglobulin M responses in children from the high-malaria region. More rapid decay of maternal antibodies was a major predictor of EBV infection outcome, because decay predicted time to EBV DNA detection, independent of high or low malaria exposure.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=27571902&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttps://doi.org/10.1093/infdis/jiw396
dc.subjectBurkitt Lymphoma
dc.subjectEpstein-Barr virus
dc.subjectP. falciparum malaria
dc.subjectantibody
dc.subjectimmunity
dc.subjectImmunology and Infectious Disease
dc.subjectInfectious Disease
dc.subjectParasitic Diseases
dc.titleModeling of EBV Infection and Antibody Responses in Kenyan Infants With Different Levels of Malaria Exposure Shows Maternal Antibody Decay is a Major Determinant of Early EBV Infection
dc.typeJournal Article
dc.source.journaltitleThe Journal of infectious diseases
dc.source.volume214
dc.source.issue9
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/faculty_pubs/1319
dc.identifier.contextkey10302880
html.description.abstract<p>The combination of Epstein-Barr virus (EBV) infection and high malaria exposure are risk factors for endemic Burkitt lymphoma, and evidence suggests that infants in regions of high malaria exposure have earlier EBV infection and increased EBV reactivation. In this study we analyzed the longitudinal antibody response to EBV in Kenyan infants with different levels of malaria exposure. We found that high malaria exposure was associated with a faster decline of maternally derived immunoglobulin G antibody to both the EBV viral capsid antigen and EBV nuclear antigen, followed by a more rapid rise in antibody response to EBV antigens in children from the high-malaria-transmission region. We also observed the long-term persistence of anti-viral capsid antigen immunoglobulin M responses in children from the high-malaria region. More rapid decay of maternal antibodies was a major predictor of EBV infection outcome, because decay predicted time to EBV DNA detection, independent of high or low malaria exposure.</p>
dc.identifier.submissionpathfaculty_pubs/1319
dc.contributor.departmentProgram in Molecular Medicine
dc.source.pages1390-1398


This item appears in the following Collection(s)

Show simple item record